Pharma Ties With Russia Could Boost Zimbabwe's Healthcare: Expert
12:17 16.11.2026 (Updated: 12:47 16.11.2026)
© telegram sputnik_africa
Subscribe
Pharma Ties With Russia Could Boost Zimbabwe's Healthcare: Expert
Zimbabwe’s push to partner with Russia on pharmaceutical manufacturing and telemedicine could transform healthcare access across the region, Zimbabwean health expert Michael Gwarisa told Sputnik Africa, commenting on the recent visit by the country's Second Vice President Kembo Mohadi to Russia to explore health cooperation.
Key points from the speaker:
🟠Local Medicine: Russian tech transfers will help Zimbabwe manufacture insulin and cancer drugs locally, cutting import costs. However, Zimbabwe must export to a broader regional market, as its 16 million population is too small to sustain production alone.
🟠Telemedicine: Remote consultations and advanced diagnostics will bridge the rural-urban divide, saving travel costs and enabling earlier disease detection.
🟠Requirements: Success relies on reliable internet, affordable data, and stable power to ensure these tools serve the public, not just the wealthy.
Zimbabwe’s push to partner with Russia on pharmaceutical manufacturing and telemedicine could transform healthcare access across the region, Zimbabwean health expert Michael Gwarisa told Sputnik Africa, commenting on the recent visit by the country's Second Vice President Kembo Mohadi to Russia to explore health cooperation.
Key points from the speaker:
🟠Local Medicine: Russian tech transfers will help Zimbabwe manufacture insulin and cancer drugs locally, cutting import costs. However, Zimbabwe must export to a broader regional market, as its 16 million population is too small to sustain production alone.
🟠Telemedicine: Remote consultations and advanced diagnostics will bridge the rural-urban divide, saving travel costs and enabling earlier disease detection.
🟠Requirements: Success relies on reliable internet, affordable data, and stable power to ensure these tools serve the public, not just the wealthy.